Elliott Haut is a General Surgeon in Baltimore, Maryland. Dr. Haut is rated as an Elite provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Venous Thromboembolism (VTE), Mesenteric Venous Thrombosis, Low Blood Pressure, Hernia Surgery, and Appendectomy.

Michael Streiff is a Hematologist in Baltimore, Maryland. Dr. Streiff is rated as an Elite provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration.

Michael Mont is an Orthopedics provider in Randallstown, Maryland. Dr. Mont is rated as a Distinguished provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Osteonecrosis, Osteoarthritis, Osteolysis Syndrome Recessive, Knee Replacement, and Hip Replacement.

Dr. Rakhi P. Naik is the Associate Director for the Division of Hematology at Johns Hopkins University. She also serves as Director of the Fellowship Hematology Track and Director of Organ Systems Foundation of Medicine (OSFM), the largest pre-clerkship course in the medical school. She holds an undergraduate degree in Biomedical & Electrical Engineering from Duke University, an M.D. with. Dr. Naik is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Hemoglobinopathy.

Dr. Shruti Chaturvedi is an Associate Professor of Medicine at Johns Hopkins. She received her medical degree from Maulana Azad Medical College, University of Delhi, India. She then completed a residency in Internal Medicine at the Cleveland Clinic, Cleveland, OH, and a fellowship in Hematology and Oncology at Vanderbilt University, Nashville, TN. She has additionally obtained a Master of Science in Clinical Investigation (MSCI) degree from Vanderbilt University. Dr. Chaturvedi specializes in the care of adults with non-malignant hematologic disorders including thrombocytopenic purpura, atypical hemolytic uremic syndrome, antiphospholpiid syndrome, immune thrombocytopenia, autoimmune hemolytic anemia, thrombotic, other bleeding and clotting disorders, and anemias. Her research is focused on improving the care of patients with thrombotic microangiopathies with a focus on long term sequelae, and the role of complement in thrombotic disorders such as the antiphospholipid syndrome. Dr. Chaturvedi is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Blood Clots, Atypical Hemolytic Uremic Syndrome (aHUS), Anemia, Splenectomy, and Bone Marrow Aspiration.

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Dr. Daniel J. Brotman is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include hospital medicine and internal medicine. Dr. Brotman earned his M.D. at the University of Virginia School of Medicine. He completed his residency at Johns Hopkins. His research interests include hospital medicine, thrombosis and anticoagulation, perioperative medicine, care coordination, and readmissions He was recognized by the Maryland Chapter of the American College of Physicians with an Outstanding Hospitalist Award in 2012, has been named a Top Doctor (hospitalist) by Baltimore Magazine multiple times since 2011, is a Fellow of the American College of Physicians (ACP), a Master in Hospital Medicine, and a member of the Miller Coulson Academy of Clinical Excellence. Dr. Brotman is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Endoscopy, and Colonoscopy.

Sarah Khan is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Khan is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Venous Thromboembolism (VTE), Pulmonary Hypertension, Interstitial Lung Disease, and Acute Interstitial Pneumonia.

Savyasachi “Savya” Thakkar, M.D., is a hip and knee reconstructive surgeon serving patients in the Baltimore, Maryland, and Washington, D.C., metro areas. His expertise is in minimally invasive hip and knee surgery, including partial and total hip and knee replacement, outpatient joint replacement and complex revisions after previous joint replacement. Dr. Thakkar uses computer and robotic-assisted techniques for these procedures to provide cutting-edge care to patients with hip and knee arthritis. Currently an Assistant Professor of Orthopaedic Surgery at Johns Hopkins, Dr. Thakkar completed his medical degree at the Johns Hopkins University School of Medicine and stayed for his residency with the Johns Hopkins Department of Orthopaedic Surgery. He was the first recipient of the Ronald P. Byank leadership award as a chief resident. He continued his training as a knee arthritis and traumatology fellow in Switzerland, followed by an adult reconstruction fellowship in New York. He then pursued the prestigious European Knee Society traveling fellowship focusing on advanced surgical techniques in the management of arthritis. Dr. Thakkar’s research interests include technological advances in the treatment of arthritis, post-traumatic arthritis, the economic impact of arthritis and the optimization of hospital protocols for arthritis management. He is also interested in exploring same-day joint replacement surgery to help patients minimize time in the hospital and maximize return to function. Dr. Thakkar is the chair of Orthopaedic Surgery at Johns Hopkins Howard County Medical Center. Dr. Thakkar is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Osteonecrosis, Osteoarthritis, Osteoporosis, Knee Replacement, and Hip Replacement.

Md Siddiqui is a Hematologist Oncology specialist and a Hematologist in Salisbury, Maryland. Dr. Siddiqui is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Pulmonary Embolism, Inflammatory Breast Cancer, Angiosarcoma, and Childhood Iron Deficiency Anemia. Dr. Siddiqui is currently accepting new patients.

Geoffrey Nguyen is a Gastroenterologist in Baltimore, Maryland. Dr. Nguyen is rated as a Distinguished provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Viral Gastroenteritis, Ulcerative Colitis, Hemorrhagic Proctocolitis, Endoscopy, and Colonoscopy.

Jun Sun is a Hematologist Oncology specialist and a Hematologist in Brandywine, Maryland. Dr. Sun is rated as a Distinguished provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Anemia, and Pulmonary Embolism. Dr. Sun is currently accepting new patients.

Nader Dakak is a Cardiologist in Glenn Dale, Maryland. Dr. Dakak is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Angina, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, and Hypertension.

Jacob Collen is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Easton, Maryland. Dr. Collen is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Obstructive Sleep Apnea, Venous Thromboembolism (VTE), Traumatic Brain Injury, and Central Sleep Apnea.

Ernest Amegashie is a Cardiologist in Hagerstown, Maryland. Dr. Amegashie is rated as an Advanced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Angina, and Glucocorticoid-Remediable Aldosteronism.

Dr. Jodi Segal is a professor of medicine at the Johns Hopkins University School of Medicine. She has joint appointments in health policy and management, and epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Segal is internationally recognized as a clinician-investigator in comparative effectiveness research and pharmacoepidemiology. She trains investigators to conduct research to advance Johns Hopkins Medicine as a learning health system. She serves as the associate director of the Center for Health Services and Outcomes Research (CHSOR) and the co-director of the Center for Drug Safety and Effectiveness (CDSE), both in the School of Public Health. Dr. Segal received a B.S. from The Pennsylvania State University. She earned her M.D. from the University of Pittsburgh School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her residency at the University of Chicago and a fellowship in general nternal medicine at Johns Hopkins. She is a member of Phi Beta Kappa and Alpha Omega Alpha. Dr. Segal is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Giant Papillary Conjunctivitis, Type 2 Diabetes (T2D), Vernal Keratoconjunctivitis, and Allergic Conjunctivitis.

Dr. Christian Pavlovich is Bernard L. Schwartz Distinguished Professor in Urologic Oncology at the Johns Hopkins University School of Medicine and Director of the Prostate Cancer Active Surveillance Program at the Brady Urological Institute. Dr. Pavlovich treats cancer with an emphasis on minimizing morbidity and maximizing quality of life while offering patients the latest treatment options and techniques. His clinical focus is on prostate and kidney cancer, and on clinical trials regarding detection, surveillance, and immunotherapy. With more than 20 years of experience with minimally-invasive surgery for the treatment of urologic cancers, he is expert in robotic surgery and was named one of the top prostate cancer surgeons in the United States by Newsweek in 2024. In addition, he offers patients modern diagnostic biopsy techniques, and for prostate cancer patients active surveillance and ablative options including cryotherapy and TULSA. Dr. Pavlovich grew up in Washington DC, went to Harvard University, and then earned his medical degree at the University of California, San Francisco (UCSF) School of Medicine. He then completed a urology residency at New York Hospital-Cornell Medical Center and a National Cancer Institute SUO fellowship in urologic oncology before joining the Hopkins faculty in 2001. Dr. Pavlovich has published over 150 peer-reviewed articles, is Associate Editor of The Prostate and is on the Editorial Board of the British Journal of Urology International. He was the inaugural Director of the Brady Urological Institute’s SUO Urologic Oncology Fellowship (2014 -2024) and is the recipient of three “best teaching/research mentor” awards from the Urology residents at Johns Hopkins. Dr. Pavlovich speaks English, French, Spanish, German, and Serbo-Croatian. He enjoys spending time with his wife and children, following their pursuits, and skiing, diving, running, wildlife, and the great outdoors. Dr. Pavlovich is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy.

Daniel Brodie is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Brodie is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Acute Respiratory Distress Syndrome (ARDS), COVID-19, Respiratory Acidosis, Lung Transplant, and Embolectomy.

Dr. Elizabeth Ratchford is a Professor of Clinical Medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include vascular medicine. Dr. Ratchford serves as the director of the Johns Hopkins Center for Vascular Medicine. Dr. Ratchford received her M.D. from the Yale University School of Medicine. She completed her residency at New York-Presbyterian Hospital/Columbia University. Her research interests include peripheral artery disease, fibromuscular dysplasia, and cardiovascular disease prevention among firefighters. Dr. Ratchford has been recognized by several honors, including the Merck Book Award from Yale University School of Medicine. She serves on the editorial board of the journal Vascular Medicine as editor of the Patient Page Section. She is currently the President of the Society for Vascular Medicine. Dr. Ratchford is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). Her top areas of expertise are Superficial Thrombophlebitis, Carotid Artery Disease, Peripheral Artery Disease, and Deep Vein Thrombosis.

Charles Lowenstein, M.D., is a cardiologist in Baltimore, Maryland. He also serves as director of the Division of Cardiology and co-director of the Johns Hopkins Heart and Vascular Institute. Dr. Lowenstein originally came to Johns Hopkins as a cardiology fellow in 1991 after completing his medical residency at Massachusetts General Hospital and a research fellowship at the Massachusetts Institute of Technology. In 1993, he joined the Johns Hopkins faculty and helped lead the Ciccarone Center for the Prevention of Heart Disease until he was recruited in 2009 to become the chief of cardiology and director of the Aab Cardiovascular Research Institute at the University of Rochester School of Medicine and Dentistry. In 2020 he was hired to lead the Division of Cardiology at Hopkins. He has served on the NIH Atherosclerosis and Inflammation Cardiovascular Sciences study section, and is a member of the Sarnoff Cardiovascular Research Foundation, an organization that funds medical student research. Dr. Lowenstein’s research focuses on vascular biology, exploring molecular mechanisms of vascular inflammation and thrombosis. Videos Dr. Charles Lowenstein. Dr. Lowenstein is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Long QT Syndrome 3, Heart Attack, Long QT Syndrome 2, Long QT Syndrome 1, and Hormone Replacement Therapy (HRT).